NanoGroup is a group of biotechnology companies currently traded on Warsaw Stock Exchange.

The group’s goal is to develop value of best projects with potential for global market expansion in the areas of: cancer prevention, early diagnostics, targeted cancer therapies ,oncological rehabilitation, human blood substitutes

Currently, the group is managing five technologically advanced nanoengineering projects organized under three specialized startups: